Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARCH-PFIC
2019-001211-22Phase 3Unknown
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in progressive familial intrahepatic cholestasis (PFIC) comparing Maralixibat with Placebo (2 arms). Primary endpoint: Mean change in average morning ItchRO(Obs) severity score. Status: unknown.
02
Drugs
maralixibat
03
Conditions
progressive familial intrahepatic cholestasis (PFIC)
Beyond the preview
Go deeper on 2019-001211-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001211-22.